GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fusion Pharm FSPM · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2012

Revenue

$808,400

FY2012FY2012

Net income

$265,200

FY2012FY2012

Free cash flow

−$121,700

FY2012FY2012

Shareholders' equity

$153,200

FY2012FY2012

Income statement

Fiscal years

FY2012
Revenue$808,400
Gross profit$676,400
Operating income$298,400
Net income$265,200
Diluted earnings per share0.10

Balance sheet

At each fiscal year end

FY2012
Total assets$591,100
Cash and short-term investments$300
Total liabilities$437,900
Debt$293,200
Shareholders' equity$153,200
Shares outstanding3m

Cash flow

Fiscal years

FY2012
Cash from operations−$115,500
Capital spending−$6,200
Free cash flow−$121,700

Latest quarters

By quarter end

Jun 2013Mar 2013Dec 2012Jun 2012Mar 2012Dec 1997Sept 1997Jun 1997
Revenue$330,300$171,600$736,600$750,000$71,800$30,000$20,000$70,000
Gross profit$149,700$86,600$643,500$732,900$32,800−$200,000−$1.0m−$270,000
Operating income$15,800$9,500$387,600$481,800−$89,100−$300,000−$1.0m−$400,000
Net income$15,800$9,500$354,400$481,800−$89,100−$410,000−$1.1m−$1.4m
Diluted earnings per share0.000.000.120.20-0.04-4.09-8.23-10.54
Total assets$634,400$610,100$591,100$695,200$155,700$1.8m$2.4m$2.7m
Cash and short-term investments$3,400$18,100$300−$1,200$1,400$1.4m$1.2m$750,000
Debt$269,800$274,500$293,300$267,700$295,700———
Shareholders' equity$277,900$176,400$153,200$425,800−$157,500$1.1m$1.6m$2.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-2.9%-37.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin72.0%-79.5%-15.8%—
Operating margin-2.8%-132.8%-33.4%—
Net margin-13.2%-73.2%-26.7%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%100%100%80114%28816%501620%39130%3610164%210653%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 200-to-1 reverse split · 1 Mar 2011
  • 200-to-1 reverse split · 15 Feb 2008
  • 15-to-1 reverse split · 25 May 2006
  • 21-for-20 split · 13 Dec 2004
  • 100-to-1 reverse split · 30 Dec 2003

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.